Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New compound may immobilize AIDS virus, certain radionuclides

15.08.2002


’Something new and exciting’ found serendipitously



A compound that could potentially immobilize the AIDS virus or selectively extract radionuclides from nuclear wastes at various U.S.high-level storage sites has been developed by a researcher at Sandia National Laboratories who wasn’t even looking for it.

An article in the current issue of Science describes characteristics of the newly discovered, extremely active compound, called niobium heteropolyanions (hetero-poly-an-ions) or HPAs.


"It wasn’t difficult to synthesize, it was luck," lead researcher May Nyman says of her discovery. "I wasn’t going after it intentionally, but after I found it, I realized I had something new and exciting."

Nyman found the right conditions to synthesize the first niobium HPA, and then tweaked to create an assortment of them.

The entities became the first niobium HPAs ever reported - basic materials formed inexpensively at the relatively benign and easily achievable temperature and pressure of boiling water.

Unlike other HPAs, niobium HPAs are basic rather than acidic, which means they can survive longer and possibly even thrive in the generally basic or neutral environments of radioactive wastes and blood, respectively.

Preliminary work with Savannah River site indicates that the new compounds do indeed selectively remove certain radionuclides from their waste solutions.

To bind viruses, researchers have tested a host of HPA compositions, says Nyman. "In these exhaustive studies, it’s been found that HPAs with small amounts of iron or niobium have an especially strong binding effect. Now we have HPAs that are completely niobium."

HPAs in the form of oxides of vanadium, tungsten, and molybdenum have been known to researchers since the late 19th century. The compounds’ peripheries consist of voraciously active oxygen ions. These have long intrigued researchers because of their capabilities to do much useful chemistry, including bind viruses and large metal atoms such as some radionuclides.

Once such compounds bind with an AIDs virus, the virus is no longer capable of entering a cell to damage it. HPAs may also bind with radionuclides called actinides, which removes them from the mixture by phase separation for easier and safer storage.

While previously known HPAs were made cheaply and easily at room temperatures and pressures, they were known to be stable only in acid environments.

This behavior means they cannot function well in blood as antiviral agents, because blood is neither acidic nor basic but instead is neutral.

Even worse, the liquid nuclear wastes at most waste sites - for example, Hanford, Savannah River, and Oak Ridge - are extremely basic. These environments attack acidic compounds and cause them to fall apart, says Nyman.

Nyman’s discovery of the base-stable HPA came about when Sandia was called upon by the Savannah River Site to find the cause of a clogging problem at the site’s attempts to extract a dangerously radioactive isotope of cesium. The extraction called for passing nuclear waste solution through a column of pebble-sized materials called zeolites that sequester cesium into tiny pores. She found that the zeolites contained small amounts of an impurity that forms during manufacturing. The acidic manufacturing treatment of the zeolites led to column-clogging behavior of the impurity. Identifying the problem concluded her task, but scientific curiosity led her to attempt to create the compound as an independent entity.

"I was curious to see if I could synthesis it pure, rather than leave it merely as a discovered impurity," says Nyman.

Her research on developing and utilizing HPAs, will be soon be supported by two Laboratory-Directed Research and Development grants, as well as the Environmental Management Science Project out of the DOE Office of Science in collaboration with Savannah River site.

"One man’s trash is another’s treasure," Nyman says of her experience. "What used to be clogging columns could now be taking out radionuclides, so it can be Savannah River’s and DOE’s treasure in the end, as well."

Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy. With main facilities in Albuquerque, N.M., and Livermore, Calif., Sandia has major R&D responsibilities in national security, energy and environmental technologies, and economic competitiveness.


###
Story and images available at www.sandia.gov/news-center/news-releases/2002/mat-chem/mayday.html
Sandia National Laboratories’ World Wide Web home page is located at http://www.sandia.gov.
Sandia news releases, news tips, science photo gallery, and periodicals can be found at the News and Events button.

Sandia National Laboratories
A Department of Energy National Laboratory
Managed and Operated by Sandia Corporation
ALBUQUERQUE, NM LIVERMORE, CA
MEDIA RELATIONS DEPARTMENT MS 0165
ALBUQUERQUE, NM 87185-0165
PHONE: 505-844-8066 FAX: 505-844-0645

Neal Singer | EurekAlert!

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>